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Results and discussion
Analysis of Mad1p immunoprecipitates revealed a regulated association with Bub1p and Bub3p ( Figure 1 ). Wild-type cells were arrested in G1 phase with α factor, washed and then released into fresh media in the presence or absence of nocodazole for time course analyses. Mad1p immunoprecipitates from the nocodazole-treated cells (Figure 1a , left panel) revealed that a Mad1p-Bub1p-Bub3p complex was formed 40 minutes after release from an α-factor arrest and was then maintained. A constant level of Mad2p was associated with Mad1p, in agreement with published work [7] .
During a normal cell cycle, one that was unperturbed by anti-microtubule disrupting agents, there was only a brief period in the cell cycle (40-60 minutes after α factor release) in which Bub1p and Bub3p were found associated with Mad1p ( Figure 1a , right panel). We suggest that this is the period in the budding yeast cell cycle in which the newly replicated centromeres have yet to form stable kinetochore-microtubule interactions. Budding yeast is unusual in that it forms a bipolar spindle relatively early in the cell cycle while DNA is still being replicated. Budding yeast centromeres are replicated early in S phase [11] and it has recently been shown that they separate before replication of the chromosome arms is completed [12] . Thus, replicated sister kinetochores could be in the process of forming bipolar spindle attachments at the time Mad1p-Bub1p-Bub3p complex formation was detected. To our knowledge, this is the first biochemical indication that the budding yeast spindle checkpoint is activated every cell cycle.
To confirm that complex formation was due to spindle checkpoint activation, rather than cell cycle position, we compared Mad1p-Bub1p-Bub3p levels in a nocodazoleinduced 'metaphase' arrest with a cdc26∆ metaphase arrest. cdc26∆ cells arrest at metaphase at their restrictive temperature due to an inactive anaphase promoting complex (APC) [13, 14] . Whereas high levels of Mad1p-Bub1p-Bub3p were detected in nocodazole arrested cells, very little was found in the cdc26∆ metaphase arrest where spindle microtubules would be attached to kinetochores (Figure 1b) .
We also analysed time courses for the abundance and modification of Bub1p and Bub3p (Figure 2 and see Supplementary material). In G1 phase, there were two distinct forms of Bub1p, whereas in mitotic samples five forms could be separated by SDS-PAGE (see Figure 2a) . Lambda protein phosphatase treatment of Bub1p immunoprecipitates showed that those forms of Bub1p were the result of phosphorylation (Figure 2b ). Bub1p modification was not enhanced by checkpoint activation, as a similar level of modification was seen in both nocodazole and cdc26∆-arrested cells (Figures 1b and 2b) . We detected similar modification of Bub1p in synchronous cultures passing through an unperturbed mitosis, found no evidence of Bub3p modification, and found that Bub3p was associated with Bub1p throughout the cell cycle (see Supplementary material). Thus, formation of the Mad1p-Bub1p-Bub3p complex does not simply reflect changes in levels of Bub1p or Bub3p. This Mad1p-Bub1p-Bub3p interaction contrasts with a number of other Mad-Bub protein complexes which are not cell cycle regulated (Mad1p-Mad2p [7] , Bub1p-Bub3p (see Supplementary material), and Mad3p-Bub3p [15] ), suggesting that it may be an important step in spindle checkpoint function.
To determine which of the other known spindle checkpoint components are necessary for the Mad1p-Bub1p-Bub3p interaction, we carried out anti-Mad1p and anti-Bub1p immunoprecipitations from extracts of nocodazole-treated checkpoint mutants. Mad2p, Bub3p and Mps1p functions were necessary for formation of a stable Mad1p-Bub1p complex, but Bub2p and Mad3p functions were not ( Figure 3 and see Supplementary material). Similar Mad1p co-immunoprecipitations revealed that Mad2p, Bub1p and Mps1p functions were required for the Mad1p-Bub3p association (data not shown). We found that very little, if any, Mad2p was associated with the Mad1p-Bub1p-Bub3p complex (data not shown). The simplest interpretation of our results is that a Mad1p-Bub1p-Bub3p complex is formed in yeast cells upon spindle checkpoint activation and that the functions of Mps1p and Mad2p are required for its formation. Perhaps in the absence of Mad2p, Mad1p does not efficiently localise to kinetochores, and it is only there that the Mad1p-Bub1p-Bub3p complex can be formed? The Mps1 requirement suggests that either Mad1p or Bub1p, or both, need to be phosphorylated for the complex to be efficiently formed and/or stabilised. Further investigation will be required to address these targetting and phosphorylation issues. Mad1p forms a complex with Bub1p and Bub3p which is cell cycle regulated. (a) Wildtype yeast cells containing Myc-tagged Bub3p (KH 228) were synchronised in G1 phase with the mating pheromone α factor and then released into rich growth media with and without the addition of 15 µg/ml nocodazole, a microtubule-disrupting agent. Immunoblot analysis of whole cell extracts revealed cell cycle position (the mitotic cyclin, Clb2p, is high in mitosis) and that Mad1p was phosphorylated in the nocodazole-treated cells. Analysis of anti-Mad1p immunoprecipitates revealed that although Mad2p was always associated with Mad1p, there was a regulated association between Mad1p and the Bub proteins. Bub3p (anti-Myc) and Bub1p were detected in the anti-Mad1p immunoprecipitates from 40 min to 60 min of the unperturbed cell cycle, and at significantly higher levels in the nocodazole-treated cells from 40 min onwards.
(b) Bub3p was immunoprecipitated, using coupled anti-Myc antibodies, from whole cell extracts made from cells arrested in G1 (with α factor), in mitosis (with nocodazole, which activates the spindle checkpoint), or at metaphase (by shifting cdc26∆ mutants to their restrictive temperature of 37°C, which does not activate the spindle checkpoint). Bub1p was always detectable in the anti-Bub3p immunoprecipitates, but Mad1p could be detected only in the nocodazole-arrested cells. 
Bub1p
Clb2p min in vitro [16] . This work and an analysis of recombinant mouse Bub3 [17] showed that whilst recombinant Bub1 was associated with Bub3, its kinase activity is not stimulated by this interaction, nor is Bub3 a substrate in immunoprecipitated Bub1 kinase assays. In addition, it was shown that although Bub3 is associated with the Mad1-Bub1 complex, Mad2 is not [16] . Thus, in vitro experiments using recombinant mammalian proteins are entirely in agreement with our immunoprecipitation analyses of native complexes from yeast extracts. Our budding
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RKALD LKKE V AERE K R I Q RLKEI F SVK SLEFR E A V FSL F G Y KLD FMPNGSVR V T S T Y SRE XlMad1 Q E L A E LKKQ V ESAE L K N Q RLR EVF Q T K IHEFR T A C Y M L T G Y RID ITTE NQYR L T S M Y GEH HsMad1 K E V A E LKKQ V ESAE L K N Q RLKEVF Q T K IQEFR K A C YTL T G Y Q I D ITTE NQYR L T S L Y AEH
ScMad1 ....KYLIA DLNENT LKSNL D A D IEG.WDD LM N L W V EDRGQL P C F L ATI TLR L W EQRQAK SpMad1
. The RLK mutant is unable to rescue a mad1∆ strain. A mad1∆ strain was transformed with plasmids containing wild-type MAD1, the mad1 RLK-AAA mutant, or an empty vector. Transformants were then spotted, at three dilutions, onto rich growth media (YPD) with or without 12.5 µg/ml of the microtubule-disrupting drug benomyl (Ben), and photographed after 3 days growth at 23°C. Microcolony assays confirmed that the mad1 RLK-AAA mutant has a checkpoint defect (data not shown). (c) The mad1 RLK-AAA mutant is stable and bindsyeast analysis has shown that a Mad1p-Bub1p-Bub3p complex is formed in vivo, revealed a requirement for both Mad2p and the Mps1 kinase in its formation, and provided information about its cell cycle regulation.
.D NTAF IFDGES . S T M K L V GNPSGPEFERLIRFWCDERKT I P G M L AAL TLE L LDKND.. XlMad1 KED NLLF K A SGSS GGKM Q LLE T D FSLTLRD FI D L H L HHQNS I P A F L SAV TLD L F S RQTFA HsMad1 PGD CLIF K A TSPS G S K M Q LLE T E FSHTVGE LIE V H L RRQDS I P A F L SSL TLE L F S
Is Bub1p's kinase activity necessary for in vivo formation of the Mad1p-Bub1p complex? Strains were constructed in which the only copy of BUB1 was the previously described bub1K733R kinase-dead mutant [9] . Two types of experiment were carried out: the spindle checkpoint was activated by overexpression of the Mps1 protein kinase [18] (Figure 3b) , and the spindle checkpoint was activated by nocodazole treatment (data not shown). In both cases, Mad1p immunoprecipitates were found to contain kinase-dead Bub1p, but it was present at lower levels than wild-type Bub1p. These experiments show that the kinase activity of Bub1p is not absolutely required for its complex formation with Mad1p. In addition, an alternative means of checkpoint activation, overexpression of the Mps1 protein kinase, also led to Mad1p-Bub1p complex formation (Figure 3b ).
What is the importance of Mad1p-Bub1p-Bub3p complex formation for spindle checkpoint function? Comparison of Mad1p homologues from several species revealed that there is little homology at the primary amino-acid sequence level [8, 19] . What little conservation there is lies towards the carboxyl terminus of Mad1p, which has been implicated in Mad2p binding [7] . We mutated a highly conserved sequence motif Arg-Leu-Lys to alanines (Figure 4a ) and found that this mutant version of Mad1p (RLK-AAA) conferred a checkpoint defect (Figure 4b ). Co-immunoprecipitations revealed that this mutation had no effect on the ability of the protein to bind to Mad2p, but that it did not co-immunoprecipitate with Bub1p or Bub3p (Figure 4c ). This conserved region of Mad1p is therefore crucial for its Bub1p-Bub3p interaction and the mutation shows that such an interaction is necessary for Mad1p's checkpoint function.
Checkpoint proteins bind to kinetochores that have not yet bound microtubules [20, 21] , and/or to kinetochores not under tension [22] . They then transmit a signal throughout the mitotic apparatus which inhibits Cdc20p function [23, 24] . As Cdc20p, the spindle checkpoint effector, is not present in the Mad1p-Bub1p-Bub3p complex (data not shown), we propose that, rather than being directly involved in Cdc20p inhibition, the Mad1p-Bub1p-Bub3p complex has an upstream signalling function. Further work will be necessary to determine how formation of this complex leads to the inhibition of Cdc20p (see model in Supplementary material).
Supplementary material
Supplementary material including a time-course of Bub1p and Bub3p expression, data showing that formation of the Mad1p-Bub1p-Bub3p complex is dependent on the functions of Mad2p and Mps1p, a model of Mad1p-Bub1p-Bub3p complex function within the spindle checkpoint and additional methodological details is available at http://current-biology.com/supmat/supmatin.htm.
